While we did not identify SB inactivation of Ncoa2 and Sav1 in our tumors, these genes were previously identified in liver cancer mouse models driven by SB mutagenesis in the presence of Myc activation or Pten loss [33,62]. This evidence concerns the gene MYC and liver cancer.